BATS BZX Real-Time Price
As of 10:59am ET
| +2.27 / +8.19%|
Hyperion Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat disorders in orphan diseases and hepatology. Its product, Ravicti is designed to lower ammonia in blood and for the treatment of urea cycle disorders and hepatic encephalopathy. The company was founded by Mark Blumling and Chris E. Rivera on November 1, 2006 and is headquartered in Brisbane, CA.
|There are no executives to display.|